These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

371 related items for PubMed ID: 8670868

  • 1. A central role for Stat3 in IL-6-induced regulation of growth and differentiation in M1 leukemia cells.
    Nakajima K, Yamanaka Y, Nakae K, Kojima H, Ichiba M, Kiuchi N, Kitaoka T, Fukada T, Hibi M, Hirano T.
    EMBO J; 1996 Jul 15; 15(14):3651-8. PubMed ID: 8670868
    [Abstract] [Full Text] [Related]

  • 2. Differentiation and growth arrest signals are generated through the cytoplasmic region of gp130 that is essential for Stat3 activation.
    Yamanaka Y, Nakajima K, Fukada T, Hibi M, Hirano T.
    EMBO J; 1996 Apr 01; 15(7):1557-65. PubMed ID: 8612579
    [Abstract] [Full Text] [Related]

  • 3. Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors.
    Hirano T, Ishihara K, Hibi M.
    Oncogene; 2000 May 15; 19(21):2548-56. PubMed ID: 10851053
    [Abstract] [Full Text] [Related]

  • 4. Interleukin-6 and oncostatin M-induced growth inhibition of human A375 melanoma cells is STAT-dependent and involves upregulation of the cyclin-dependent kinase inhibitor p27/Kip1.
    Kortylewski M, Heinrich PC, Mackiewicz A, Schniertshauer U, Klingmüller U, Nakajima K, Hirano T, Horn F, Behrmann I.
    Oncogene; 1999 Jun 24; 18(25):3742-53. PubMed ID: 10391682
    [Abstract] [Full Text] [Related]

  • 5. Association of Stat3-dependent transcriptional activation of p19INK4D with IL-6-induced growth arrest.
    Narimatsu M, Nakajima K, Ichiba M, Hirano T.
    Biochem Biophys Res Commun; 1997 Sep 29; 238(3):764-8. PubMed ID: 9325164
    [Abstract] [Full Text] [Related]

  • 6. Inhibition by interleukin 4 of leukemia inhibitory factor-, interleukin 6-, and dexamethasone-induced differentiation of mouse myeloid leukemia cells: role of c-myc and junB proto-oncogenes.
    Kasukabe T, Okabe-Kado J, Hozumi M, Honma Y.
    Cancer Res; 1994 Jan 15; 54(2):592-7. PubMed ID: 8275499
    [Abstract] [Full Text] [Related]

  • 7. Differentiation primary response genes and proto-oncogenes as positive and negative regulators of terminal hematopoietic cell differentiation.
    Liebermann DA, Hoffman B.
    Stem Cells; 1994 Jul 15; 12(4):352-69. PubMed ID: 7951003
    [Abstract] [Full Text] [Related]

  • 8. STAT3 is dispensable for maintenance of self-renewal in nonhuman primate embryonic stem cells.
    Sumi T, Fujimoto Y, Nakatsuji N, Suemori H.
    Stem Cells; 2004 Jul 15; 22(5):861-72. PubMed ID: 15342949
    [Abstract] [Full Text] [Related]

  • 9. Structure and function of a new STAT-induced STAT inhibitor.
    Naka T, Narazaki M, Hirata M, Matsumoto T, Minamoto S, Aono A, Nishimoto N, Kajita T, Taga T, Yoshizaki K, Akira S, Kishimoto T.
    Nature; 1997 Jun 26; 387(6636):924-9. PubMed ID: 9202127
    [Abstract] [Full Text] [Related]

  • 10. IL-10 inhibits macrophage activation and proliferation by distinct signaling mechanisms: evidence for Stat3-dependent and -independent pathways.
    O'Farrell AM, Liu Y, Moore KW, Mui AL.
    EMBO J; 1998 Feb 16; 17(4):1006-18. PubMed ID: 9463379
    [Abstract] [Full Text] [Related]

  • 11. FR901228, an inhibitor of histone deacetylases, increases the cellular responsiveness to IL-6 type cytokines by enhancing the expression of receptor proteins.
    Blanchard F, Kinzie E, Wang Y, Duplomb L, Godard A, Held WA, Asch BB, Baumann H.
    Oncogene; 2002 Sep 12; 21(41):6264-77. PubMed ID: 12214267
    [Abstract] [Full Text] [Related]

  • 12. Characterization of the roles of STAT1 and STAT3 signal transduction pathways in mammalian lens development.
    Ebong S, Chepelinsky AB, Robinson ML, Zhao H, Yu CR, Egwuagu CE.
    Mol Vis; 2004 Feb 19; 10():122-31. PubMed ID: 14978477
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Enhancement of gp130-mediated tyrosine phosphorylation of STAT3 and its DNA-binding activity in dexamethasone-treated AIDS-associated Kaposi's sarcoma cells: selective synergy between dexamethasone and gp130-related growth factors in Kaposi's sarcoma cell proliferation.
    Murakami-Mori K, Mori S, Taga T, Kishimoto T, Nakamura S.
    J Immunol; 1997 Jun 01; 158(11):5518-26. PubMed ID: 9164976
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. STAT3 exerts two-way regulation in the biological effects of IL-6 in M1 leukemia cells.
    Zhang J, Shen B, Li Y, Sun Y.
    Leuk Res; 2001 Jun 01; 25(6):463-72. PubMed ID: 11337018
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. MyD genes in negative growth control.
    Liebermann DA, Hoffman B.
    Oncogene; 1998 Dec 24; 17(25):3319-29. PubMed ID: 9916994
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.